We treated mice with Keap1 R470C mutant lung tumors with DRP-104 and/or anti-PD1 and harvested whole lungs for single-cell analysis after 5 days of treatment (Fig. 4A), a time point where tumor burden differences among treatment arms are minimal (Fig. 3C). This evidence concerns the gene PDCD1 and neoplasm.